NQBTR Trademark

Trademark Overview

On Monday, March 1, 2021, a trademark application was filed for NQBTR with the United States Patent and Trademark Office. The USPTO has given the NQBTR trademark a serial number of 90553816. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, October 29, 2024. This trademark is owned by Bayer Aktiengesellschaft. The NQBTR trademark is filed in the Insurance & Financial Services category with the following description:

Providing venture capital, development capital, private equity and investment funding, all of the foregoing in the field of life sciences
nqbtr

General Information

Serial Number90553816
Word MarkNQBTR
Filing DateMonday, March 1, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, October 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements

Goods and ServicesProviding venture capital, development capital, private equity and investment funding, all of the foregoing in the field of life sciences

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSunday, May 30, 2021
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBayer Aktiengesellschaft
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLeverkusen 51373
DE
Party NameBayer Aktiengesellschaft
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLeverkusen 51373
DE

Trademark Events

Event DateEvent Description
Friday, July 23, 2021NON-FINAL ACTION E-MAILED
Thursday, March 4, 2021NEW APPLICATION ENTERED
Sunday, May 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 21, 2021ASSIGNED TO EXAMINER
Friday, July 23, 2021NON-FINAL ACTION WRITTEN
Friday, July 23, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 4, 2022NON-FINAL ACTION WRITTEN
Friday, February 4, 2022NON-FINAL ACTION E-MAILED
Friday, February 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 18, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 15, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 15, 2022SOU EXTENSION 1 FILED
Tuesday, November 15, 2022SOU EXTENSION 1 GRANTED
Thursday, November 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 22, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 22, 2023SOU EXTENSION 2 FILED
Monday, May 22, 2023SOU EXTENSION 2 GRANTED
Wednesday, May 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 23, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 23, 2023SOU EXTENSION 3 FILED
Monday, October 23, 2023SOU EXTENSION 3 GRANTED
Wednesday, October 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 18, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 18, 2024SOU EXTENSION 4 FILED
Thursday, April 18, 2024SOU EXTENSION 4 GRANTED
Friday, April 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 29, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 29, 2024SOU EXTENSION 5 FILED
Tuesday, October 29, 2024SOU EXTENSION 5 GRANTED

Related Keywords

nqbtr capital foregoing field life funding sciences equity venture development private